SND1 and colorectal carcinoma: All the data not only provided the molecular mechanism insights into the expression regulation of hTERT in CRC initiation and development, but also put forward the possibility that inhibiting SPT6‐SND1‐hTERT axis simultaneously might create a therapeutic vulnerability in CRC.